Sub-Q Bionics is a medtech company, that aids the management of chronic pain and debilitating symptoms of lymphedema specially for women.
Sub-Q Bionics has raised $1.5M in total funding. The most recent round was Pre-Seed. The last funding was announced in March 2026.
Sub-Q Bionics's investors include Mayo Clinic, Israel Innovation Authority, Yeda Research and Development Co. Ltd, Filter Fund VC.
Sub-Q Bionics is headquartered in Minneapolis, United States.
Sub-Q Bionics is a medtech company, that aids the management of chronic pain and debilitating symptoms of lymphedema specially for women.
Sub-Q Bionics is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sub-Q Bionics — Funding & Investors." VCBacked, March 31, 2026, https://www.vcbacked.co/company/sub-q-bionics. Accessed September 30, 2026.
VCBacked. (2026). Sub-Q Bionics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/sub-q-bionics
{{cite web |title=Sub-Q Bionics — Funding & Investors |url=https://www.vcbacked.co/company/sub-q-bionics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated